Nitric oxide formation contributes to beta-adrenergic dilation of epicardial coronary arteries in response to intravenous administration of dobutamine in dogs

J Huazhong Univ Sci Technolog Med Sci. 2004;24(2):189-91. doi: 10.1007/BF02885426.

Abstract

To examine the role of nitric oxide in the beta-adrenergic vasodilation of epicardial coronary arteries in dogs, 12 dogs were instrumented for measurement of left anterior descending coronary artery diameter by transthoracic echocardiography before and after dobutamine (5 microg/kg/min IV) with and without intracoronary infusion of NG-monomethyl-L-arginine (L-NMMA) (1 mg/kg). In all 12 dogs, the diameter of left anterior descending coronary artery increased significantly from 2.35 +/- 0.25 mm to 2.59 +/- 0.24 mm (P<0.001) after dobutamine administration. In 6 of the 12 dogs, the percent change in left anterior descending coronary artery diameter induced by dobutamine decreased significantly from 12.5% +/- 8.6% to -1.5% +/- 5.4% (P<0.05) after the administration of intracoronary L-NMMA (1 mg/kg for 5 min) to block nitric oxide synthesis from L-arginine. The study demonstrated that nitric oxide formation contributes to the beta-adrenergic dilatory response of epicardial coronary arteries to dobutamine in dogs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Coronary Vessels / physiology*
  • Dobutamine / pharmacology*
  • Dogs
  • Echocardiography
  • Female
  • Male
  • Nitric Oxide / physiology*
  • Receptors, Adrenergic, beta / physiology*
  • Vasodilation / physiology*
  • omega-N-Methylarginine / pharmacology

Substances

  • Adrenergic beta-Agonists
  • Receptors, Adrenergic, beta
  • omega-N-Methylarginine
  • Nitric Oxide
  • Dobutamine